BioClinica has signed a three-year multi-million dollar deal with bio-pharmaceutical company Cephalon for clinical trial technology and support services.
As part of the service agreement, US-based data management staff at Cephalon will be hired by BioClinica to support clinical efforts of Cephalon.
BioClinica will provide clinical data management services to Cephalon global clinical trial operations. Specific tasks include data management planning, clinical study set-up for electronic data capture (EDC), medical coding, adverse event reconciliation, clinical data management, and training for the clinical sites and investigators.
BioClinica claims that the deal also expands plans by Cephalon to use its Express EDC product as the default data capture system across clinical trial phases, from Phases I through IV.
BioClinica will work with other functional service providers selected as part of Cephalon’s initiative to optimize operational efficiency. BioClinica said it will see its role with Cephalon extended from one of a technology provider to that of a key services partner.
Mark Weinstein, president and CEO of BioClinica, said: “We will help Cephalon centralize and streamline its clinical data management operations through improved process standardization, consistency of delivery, economies of scale and cost savings.
“There are other technology players out there and certainly no shortage of service-based CROs, but BioClinica is the only organization that successfully blends those models into a true eClinical suite.”
Will the deal help BioClinica in providing better services?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.
User Comments